eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Sanofi-aventis - Comment

Sanofi-aventis - Comment

Document ID: FDA-2008-N-0032-0004
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: March 07 2008, at 09:07 AM Eastern Standard Time
Date Posted: March 7 2008, at 12:00 AM Eastern Standard Time
Comment Start Date: January 16 2008, at 12:00 AM Eastern Standard Time
Comment Due Date: March 17 2008, at 11:59 PM Eastern Standard Time
Tracking Number: 803eafee
View Document:  View as format xml

View Comment

Attached are sanofi-aventis comments for this proposed rule. ...Attached are sanofi-aventis comments for this proposed rule....

Attachments:

Sanofi-aventis - Comment

Title:
Sanofi-aventis - Comment

Abstract:
Brian E. Harvey, M.D., Ph.D., Vice President, Regulatory Policy...Sanofi-aventis U.S. LLC appreciates the opportunity to comment on the above-referenced proposed rule....

View Attachment: View as format pdf

Related Comments

    View All
Total: 24
Tom Ellis - Comment
Public Submission    Posted: 02/19/2008     ID: FDA-2008-N-0032-0002

Mar 17,2008 11:59 PM ET
Rebecca Griffith - Comment
Public Submission    Posted: 02/19/2008     ID: FDA-2008-N-0032-0003

Mar 17,2008 11:59 PM ET
Sanofi-aventis - Comment
Public Submission    Posted: 03/07/2008     ID: FDA-2008-N-0032-0004

Mar 17,2008 11:59 PM ET
Sanofi-aventis - Comment
Public Submission    Posted: 03/12/2008     ID: FDA-2008-N-0032-0006

Mar 17,2008 11:59 PM ET
American Association for Justice - Comment
Public Submission    Posted: 03/17/2008     ID: FDA-2008-N-0032-0007

Mar 17,2008 11:59 PM ET